Evaluating laser treatment for knee osteoarthritis after PRP injection
Knee Osteoarthritis and Lazer Therapy
This study is testing if adding laser treatment to regular physiotherapy can help people with knee osteoarthritis feel less pain and move better after getting PRP injections.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Karabuk University Academic / other |
| Locations | 1 site (Karabük) |
| Trial ID | NCT06432842 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of laser treatment combined with conventional physiotherapy in improving pain, function, muscle strength, and balance in patients with knee osteoarthritis who have received platelet-rich plasma (PRP) injections. Osteoarthritis is a common degenerative joint disease characterized by cartilage destruction and associated symptoms such as pain and limited movement. The study will include patients diagnosed with unilateral knee OA, specifically those in stages I to III of the Kellgren-Lawrence classification, aged between 18 and 65. By investigating the synergistic effects of laser therapy, the study seeks to provide insights into enhanced rehabilitation strategies for knee OA.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18-65 diagnosed with unilateral knee osteoarthritis who have received a PRP injection.
Not a fit: Patients with stage IV knee osteoarthritis or those with a BMI over 40 kg/m2 may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and functional outcomes for patients with knee osteoarthritis.
How similar studies have performed: While there are various studies on treatment options for osteoarthritis, this specific combination of laser treatment with PRP has not been extensively tested, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteering to participate in the study * Being diagnosed with knee OA by a specialist physician * Having had PRP injection applied by a specialist physician * Having unilateral knee OA * Being stage I-stage III in the Kellgren-Lawrence OA classification * Being between the ages of 18-65 Exclusion Criteria: * Being stage IV in the Kellgren-Lawrence OA classification * BMI being more than 40 kg/m2 * Patients who do not cooperate well * Patients with neurological or neuromuscular disease
Where this trial is running
Karabük
- Karabük University — Karabük, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Sevde Nur AKTAŞ, MsC
- Email: sevdenur9880@icloud.com
- Phone: 05438760764
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.